Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126460791 | 12646079 | 1 | I | 2002 | 20160805 | 20160811 | 20160811 | EXP | US-ASTRAZENECA-2016SE85844 | ASTRAZENECA | 49.00 | YR | F | Y | 0.00000 | 20160812 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126460791 | 12646079 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 40 | MG | QD | ||||||
| 126460791 | 12646079 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 40 | MG | QD | ||||||
| 126460791 | 12646079 | 3 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 40 | MG | BID | ||||||
| 126460791 | 12646079 | 4 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 40 | MG | BID | ||||||
| 126460791 | 12646079 | 5 | SS | NEXIUM 24HR | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | 44 | MG | BID | ||||||||
| 126460791 | 12646079 | 6 | SS | NEXIUM 24HR | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | 44 | MG | BID | ||||||||
| 126460791 | 12646079 | 7 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | 20 | MG | QD | ||||||
| 126460791 | 12646079 | 8 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | 20 | MG | QD | ||||||
| 126460791 | 12646079 | 9 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | 40 | MG | QD | ||||||
| 126460791 | 12646079 | 10 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | 40 | MG | QD | ||||||
| 126460791 | 12646079 | 11 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | 40 | MG | BID | ||||||
| 126460791 | 12646079 | 12 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | 40 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126460791 | 12646079 | 1 | Gastrooesophageal reflux disease |
| 126460791 | 12646079 | 2 | Gastrooesophageal reflux disease |
| 126460791 | 12646079 | 3 | Gastrooesophageal reflux disease |
| 126460791 | 12646079 | 4 | Gastrooesophageal reflux disease |
| 126460791 | 12646079 | 5 | Gastrooesophageal reflux disease |
| 126460791 | 12646079 | 6 | Gastrooesophageal reflux disease |
| 126460791 | 12646079 | 7 | Gastrooesophageal reflux disease |
| 126460791 | 12646079 | 8 | Gastrooesophageal reflux disease |
| 126460791 | 12646079 | 9 | Gastrooesophageal reflux disease |
| 126460791 | 12646079 | 10 | Gastrooesophageal reflux disease |
| 126460791 | 12646079 | 11 | Gastrooesophageal reflux disease |
| 126460791 | 12646079 | 12 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126460791 | 12646079 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126460791 | 12646079 | Drug ineffective | |
| 126460791 | 12646079 | Product use issue | |
| 126460791 | 12646079 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126460791 | 12646079 | 1 | 2004 | 0 | ||
| 126460791 | 12646079 | 2 | 2004 | 0 | ||
| 126460791 | 12646079 | 3 | 201603 | 0 | ||
| 126460791 | 12646079 | 4 | 201603 | 0 | ||
| 126460791 | 12646079 | 5 | 201603 | 0 | ||
| 126460791 | 12646079 | 6 | 201603 | 0 | ||
| 126460791 | 12646079 | 7 | 2002 | 0 | ||
| 126460791 | 12646079 | 8 | 2002 | 0 |